Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Night Procedure The purpose of this study is to evaluate the effect of the night procedure in regards to colon cleansing level and capsule excretion rate.

• Country Germany
• organs None
• Specialty None

Nimotuzumab in Adults With Glioblastoma Multiforma Determination of efficiency of nimotuzumab in adults with glioblastoma multiforma

• Country Germany
• organs None
• Specialty None

Influence of a rehabilitative exercise program on physical, psychological and psychosocial parameters in prostate cancer patients

• Country Germany
• organs None
• Specialty None

Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy A study to assess the safety and efficacy of 2 different doses of CDP870 versus placebo, administered during 12 weeks, to patients suffering from moderate to severe chronic plaque psoriasi...

• Country France, Germany
• organs None
• Specialty None

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes This study will compare the immunogenicity and safety of the MeMuRu-OKA vaccine administered subcutaneously or using an alternative administration route.

• Country Germany
• organs None
• Specialty None

BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab The overall purpose of this trial is to assess clinical efficacy and safety of different subcutaneous doses of BI 655066 in adult patients with chronic plaque psoriasis in order to select ...

• Country Canada, Finland, France, Germany, Norway, Sweden, United States
• organs None
• Specialty None

A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate This study is a Phase 2 randomized, double-blind, double-dummy, active- and placebo-controlled, parallel-group study designed to assess the safety, tolerability, efficacy, pharmacokinetics...

• Country Australia, Bulgaria, Czech Republic, France, Germany, Hungary, Italy, Latvia, New Zealand, Poland, Romania, Spain, United States
• organs None
• Specialty None

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease The purpose of this study is to determine the long term safety and clinical utility of IPX066 in subjects with Parkinson's Disease.

• Country Canada, Estonia, Germany, Latvia, Lithuania, Poland, Romania, Spain, Ukraine, United States
• organs None
• Specialty None

PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer The study is intended to investigate the safety of BYL719 and AUY922 in patients with advanced gastric cancer, and to determine the MTD and/or RDE of both drugs in combination. In addition...

• Country Germany, Japan, Korea, Republic of, Switzerland, Taiwan, Province of China, United States
• organs None
• Specialty None

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis The aim of the study is to evaluate the efficacy and safety of LAS41008 in comparison to active control and placebo in patients with moderate to severe chronic plaque psoriasis

• Country Austria, Germany, Netherlands, Poland
• organs None
• Specialty None